AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties

Narender R. Gavva(Amgen (United States)), Rami Tamir, Yusheng Qu, Lana Klionsky, T. J. Zhang, David Immke, Luyu Wang, Dawn Zhu, Todd W. Vanderah, Frank Porreca, Elizabeth M. Doherty, Mark H. Norman, Kenneth D. Wild, Anthony W. Bannon, Jean-Claude Louis, James Treanor

Journal of Pharmacology and Experimental Therapeutics

March 18, 2005

10.1124/jpet.104.079855

Cited by 388

Abstract

Related Papers

No related papers found

Powered by citation graph analysis